Guiding Principles for Chronic Total Occlusion Percutaneous Coronary Intervention.


Journal

Circulation
ISSN: 1524-4539
Titre abrégé: Circulation
Pays: United States
ID NLM: 0147763

Informations de publication

Date de publication:
30 07 2019
Historique:
entrez: 30 7 2019
pubmed: 30 7 2019
medline: 25 4 2020
Statut: ppublish

Résumé

Outcomes of chronic total occlusion (CTO) percutaneous coronary intervention (PCI) have improved because of advancements in equipment and techniques. With global collaboration and knowledge sharing, we have identified 7 common principles that are widely accepted as best practices for CTO-PCI.  1. Ischemic symptom improvement is the primary indication for CTO-PCI.  2. Dual coronary angiography and in-depth and structured review of the angiogram (and, if available, coronary computed tomography angiography) are key for planning and safely performing CTO-PCI.  3. Use of a microcatheter is essential for optimal guidewire manipulation and exchanges.  4. Antegrade wiring, antegrade dissection and reentry, and the retrograde approach are all complementary and necessary crossing strategies. Antegrade wiring is the most common initial technique, whereas retrograde and antegrade dissection and reentry are often required for more complex CTOs.  5. If the initially selected crossing strategy fails, efficient change to an alternative crossing technique increases the likelihood of eventual PCI success, shortens procedure time, and lowers radiation and contrast use.  6. Specific CTO-PCI expertise and volume and the availability of specialized equipment will increase the likelihood of crossing success and facilitate prevention and management of complications, such as perforation.  7. Meticulous attention to lesion preparation and stenting technique, often requiring intracoronary imaging, is required to ensure optimum stent expansion and minimize the risk of short- and long-term adverse events. These principles have been widely adopted by experienced CTO-PCI operators and centers currently achieving high success and acceptable complication rates. Outcomes are less optimal at less experienced centers, highlighting the need for broader adoption of the aforementioned 7 guiding principles along with the development of additional simple and safe CTO crossing and revascularization strategies through ongoing research, education, and training.

Identifiants

pubmed: 31356129
doi: 10.1161/CIRCULATIONAHA.119.039797
doi:

Types de publication

Journal Article Review

Langues

eng

Sous-ensembles de citation

IM

Pagination

420-433

Auteurs

Emmanouil S Brilakis (ES)

Minneapolis Heart Institute and Minneapolis Heart Institute Foundation, Abbott Northwestern Hospital, MN (E.S.B., M.N.B.).

Kambis Mashayekhi (K)

Department of Cardiology and Angiology II University Heart Center Freiburg Bad Krozingen, Germany (K.M., H.J.B.).

Etsuo Tsuchikane (E)

Toyohashi Heart Center, Aichi, Japan (E.T.).

Nidal Abi Rafeh (N)

St. George Hospital University Medical Center, Beirut, Lebanon (N.A.R.).

Khaldoon Alaswad (K)

Henry Ford Hospital, Detroit, MI (K.A.).

Mario Araya (M)

Clínica Alemana and Instituto Nacional del Tórax, Santiago, Chile (M.A.).

Alexandre Avran (A)

Arnault Tzank Institut St. Laurent Du Var Nice, France (A.A.).

Lorenzo Azzalini (L)

Interventional Cardiology Division, Cardio-Thoracic-Vascular Department, San Raffaele Scientific Institute, Milan, Italy (L.A., M.C.).

Avtandil M Babunashvili (AM)

Department of Cardiovascular Surgery, Center for Endosurgery and Lithotripsy, Moscow, Russian Federation (A.M.B.).

Baktash Bayani (B)

Cardiology Department, Mehr Hospital, Mashhad, Iran (B.B.).

Ravinay Bhindi (R)

Department of Cardiology, Royal North Shore Hospital and Kolling Institute, University of Sydney, Australia (R.B.).

Nicolas Boudou (N)

Rangueil University Hospital, Toulouse, France (N.B.).

Marouane Boukhris (M)

Cardiology department, Abderrahment Mami Hospital, Faculty of Medicine of Tunis, University of Tunis El Manar, Tunisia (M.B.).

Nenad Ž Božinović (NŽ)

Department of Interventional Cardiology Clinic for Cardiovascular Diseases University Clinical Center Nis, Serbia (N.Z.B.).

Leszek Bryniarski (L)

II Department of Cardiology and Cardiovascular Interventions Institute of Cardiology, Jagiellonian University Medical College, Cracow, Poland (L.B.).

Alexander Bufe (A)

Department of Cardiology, Heartcentre Niederrhein, Helios Clinic Krefeld, Krefeld, Germany, Institute for Heart and Circulation Research, University of Cologne, Germany, and University of Witten/Herdecke, Witten, Germany (A.B.).

Christopher E Buller (CE)

St. Michael's Hospital, Toronto, ON, Canada (C.E.B.).

M Nicholas Burke (MN)

Minneapolis Heart Institute and Minneapolis Heart Institute Foundation, Abbott Northwestern Hospital, MN (E.S.B., M.N.B.).

Heinz Joachim Büttner (HJ)

Department of Cardiology and Angiology II University Heart Center Freiburg Bad Krozingen, Germany (K.M., H.J.B.).

Pedro Cardoso (P)

Cardiology Department, Santa Maria University Hospital (CHULN), Lisbon Academic Medical Centre (CAML) and Centro Cardiovascular da Universidade de Lisboa (CCUL), Portugal (P.C.).

Mauro Carlino (M)

Interventional Cardiology Division, Cardio-Thoracic-Vascular Department, San Raffaele Scientific Institute, Milan, Italy (L.A., M.C.).

Evald H Christiansen (EH)

Department of Cardiology, Aarhus University Hospital, Denmark (E.H.C.).

Antonio Colombo (A)

San Raffaele Hospital and Columbus Hospital, Milan, Italy (A.C.).

Kevin Croce (K)

Cardiovascular Division, Brigham and Women's Hospital, Boston, MA (K.C.).

Felix Damas de Los Santos (F)

Interventional Cardiology Department, Instituto Nacional de Cardiología Ignacio Chávez Mexico City, Mexico (F.D.d.l.S.).

Tony De Martini (T)

SIU School of Medicine, Memorial Medical Center, Springfield, IL (T.D.M.).

Joseph Dens (J)

Department of Cardiology, Hospital Oost-Limburg, Genk, Belgium (J.D.).

Carlo Di Mario (C)

Structural Interventional Cardiology, Careggi University Hospital, Florence, Italy (C.D.M.).

Kefei Dou (K)

Center for Coronary Heart Disease, State Key Laboratory of Cardiovascular Disease, Fu Wai Hospital, and National Center for Cardiovascular Diseases, Chinese Academy of Medical Sciences and Peking Union Medical College, Beijing (K.D.).

Mohaned Egred (M)

Freeman Hospital and Newcastle University, Newcastle upon Tyne, United Kingdom (M.E.).

Ahmed M ElGuindy (AM)

Department of Cardiology, Aswan Heart Center, Egypt (A.M.E.).
National Heart and Lung Institute, Imperial College London, United Kingdom (A.M.E.).

Javier Escaned (J)

Hospital Clinico San Carlos IDISSC and Universidad Complutense de Madrid, Spain (J.E.).

Sergey Furkalo (S)

Department of Endovascular Surgery and Angiography, National Institute of Surgery and Transplantology of AMS of Ukraine, Kiev (S.F.).

Andrea Gagnor (A)

Department of Invasive Cardiology, Maria Vittoria Hospital, Turin, Italy (A.G.).

Alfredo R Galassi (AR)

Chair of Cardiology, Department of PROMISE, University of Palermo, Italy (A.R.G.).

Roberto Garbo (R)

Director of Interventional Cardiology, San Giovanni Bosco Hospital, Turin, Italy (R.G.).

Junbo Ge (J)

Zhongshan Hospital, Fudan University, Shanghai, China (J.G.).

Pravin Kumar Goel (PK)

Sanjay Gandhi Post Graduate Institute of Medical Sciences Lucknow, India (P.K.G.).

Omer Goktekin (O)

Memorial Hospital, Istanbul, Turkey (O.G.).

Luca Grancini (L)

Centro Cardiologico Monzino, IRCCS, Milan, Italy (L.G.).

J Aaron Grantham (JA)

Saint Luke's Mid America Heart Institute, Kansas City, MO (J.A.G.).

Colm Hanratty (C)

Belfast Health and Social Care Trust, United Kingdom (C.H., S.W.).

Stefan Harb (S)

LKH Graz II, Standort West, Kardiologie, Teaching Hospital of the University of Graz, Austria (S.H.).

Scott A Harding (SA)

Wellington Hospital, Capital and Coast District Health Board, New Zealand (S.A.H.).

Jose P S Henriques (JPS)

Academic Medical Centre of the University of Amsterdam, The Netherlands (J.P.S.H.).

Jonathan M Hill (JM)

King's College Hospital, London, United Kingdom (J.M.H.).

Farouc A Jaffer (FA)

Cardiology Division, Massachusetts General Hospital, Boston (F.A.J.).

Yangsoo Jang (Y)

Division of Cardiology, Severance Cardiovascular Hospital, Yonsei University Health System, Seoul, South Korea (Y.J.).

Risto Jussila (R)

Helsinki Heart Hospital, Finland (R.J.).

Artis Kalnins (A)

Department of Cardiology, Eastern Clinical University Hospital, Riga, Latvia (A. Kalnins).

Arun Kalyanasundaram (A)

Promed Hospital, Chennai, India (A. Kalyanasundaram).

David E Kandzari (DE)

Piedmont Heart Institute, Atlanta, GA (D.E.K.).

Hsien-Li Kao (HL)

Department of Internal Medicine, National Taiwan University Hospital, Taipei(H.-L.K.).

Dimitri Karmpaliotis (D)

Columbia University, New York (D.K.).

Hussien Heshmat Kassem (HH)

Cardiology Department, Kasr Al-Ainy Faculty of Medicine, Cairo University, Egypt(H.H.K.).
Fujairah Hospital, United Arab Emirates (H.H.K.).

Paul Knaapen (P)

Department of Cardiology, VU University Medical Center, Amsterdam, The Netherlands (P.K.).

Ran Kornowski (R)

Department of Cardiology, Rabin Medical Center, Petach Tikva, "Sackler" School of Medicine, Tel Aviv University, Petach Tikva, Israel (R.K.).

Oleg Krestyaninov (O)

Meshalkin Novosibrisk Research Institute, Russia (O.K.).

A V Ganesh Kumar (AVG)

Department of Cardiology, Dr LH Hiranandani Hospital, Mumbai, India (A.V.G.K.).

Peep Laanmets (P)

North Estonia Medical Center Foundation, Tallinn, Estonia(P. Laanmets).

Pablo Lamelas (P)

Department of Interventional Cardiology and Endovascular Therapeutics, Instituto Cardiovascular de Buenos Aires, Argentina (P. Lamelas).
Department of Health Research Methods, Evidence and Impact, McMaster University, Hamilton, ON, Canada (P. Lamelas).

Seung-Whan Lee (SW)

Department of Cardiology, Asan Medical Center, University of Ulsan College of Medicine, Seoul, South Korea (S.-W.L.).

Thierry Lefevre (T)

Institut Cardiovasculaire Paris Sud Hopital prive Jacques Cartier, Massy, France (T.L.).

Yue Li (Y)

Department of Cardiology, the First Affiliated Hospital of Harbin Medical University, China (Y.L.).

Soo-Teik Lim (ST)

Department of Cardiology, National Heart Centre Singapore (S.-T.L.).

Sidney Lo (S)

Department of Cardiology, Liverpool Hospital and The University of New South Wales, Sydney, Australia (S.L.).

William Lombardi (W)

University of Washington, Seattle (W.L.).

Margaret McEntegart (M)

Golden Jubilee National Hospital, Glasgow, United Kingdom (M. McEntegart).

Muhammad Munawar (M)

Binawaluya Cardiac Center, Jakarta, Indonesia (M. Munawar).

José Andrés Navarro Lecaro (JA)

Médico Cardiólogo Universitario - Hemodinamista en Hospital de Especialidades Eugenio Espejo y Hospital de los Valles, Ecuador (J.A.N.L.).

Hung M Ngo (HM)

Choray Hospital, Vietnam (H.M.N.).

William Nicholson (W)

WellSpan Health System, York, PA (W.N.).

Göran K Olivecrona (GK)

Skane University Hospital, University of Lund, Sweden (G.K.O.).

Lucio Padilla (L)

Department of Interventional Cardiology and Endovascular Therapeutics, ICBA, Instituto Cardiovascular, Buenos Aires, Argentina (L.P.).

Marin Postu (M)

Cardiology Department, University of Medicine and Pharmacy "Carol Davila," Institute of Cardiovascular Diseases "Prof. Dr. C.C. Iliescu," Bucharest, Romania (M.P.).

Alexandre Quadros (A)

Instituto de Cardiologia / Fundação Universitária de Cardiologia - IC/FUC, Porto Alegre, RS - Brazil (A.Q.).

Franklin Hanna Quesada (FH)

Interventional Cardiology Department, Clinica Comfamiliar Pereira City, Colombia (F.H.Q.).

Vithala Surya Prakasa Rao (VS)

Hyderguda Apollo, Hyderabad, India (V.S.P.R.).

Nicolaus Reifart (N)

Department of Cardiology, Main Taunus Heart Institute, Bad Soden, Germany (N.R.).

Meruzhan Saghatelyan (M)

Nork-Marash Medical Center, Yerevan, Armenia (M.S.).

Ricardo Santiago (R)

Hospital Pavia Santurce, PCI Cardiology Group, San Juan, Puerto Rico (R.S.T.).

George Sianos (G)

AHEPA University Hospital, Thessaloniki, Greece (G.S.).

Elliot Smith (E)

Department of Cardiology, Barts Heart Centre, St Bartholomew's Hospital, London, United Kingdom (E.S.).

James C Spratt (J)

St George's University Hospital NHS Trust, London, United Kingdom (J.S.).

Gregg W Stone (GW)

Center for Interventional Vascular Therapy, Division of Cardiology, New York-Presbyterian Hospital/Columbia University Medical Center (G.W.S.).

Julian W Strange (JW)

Department of Cardiology, Bristol Royal Infirmary, United Kingdom (J.W.S.).

Khalid Tammam (K)

Cardiac Center of Excellence, International Medical Center, Jeddah, Saudi Arabia (K.T.).

Imre Ungi (I)

2nd Department of Internal Medicine and Cardiology Center, University of Szeged, Hungary (I.U.).

Minh Vo (M)

Mazankowski Alberta Heart Institute, Edmonton, AB, Canada (M.V.).

Vu Hoang Vu (VH)

Interventional Cardiology Department, Heart Center, University Medical Center at Ho Chi Minh City, and University of Medicine and Pharmacy, Vietnam (H.V.).

Simon Walsh (S)

Belfast Health and Social Care Trust, United Kingdom (C.H., S.W.).

Gerald S Werner (GS)

Medizinische Klinik I Klinikum Darmstadt GmbH, Germany (G.W.).

Jason R Wollmuth (JR)

Providence Heart and Vascular Institute, Portland, OR (J.R.W.).

Eugene B Wu (EB)

Prince of Wales Hospital, Hong Kong (E.W.).

R Michael Wyman (RM)

Torrance Memorial Medical Center, CA (R.M.W.).

Bo Xu (B)

Fu Wai Hospital, National Center for Cardiovascular Diseases, Chinese Academy of Medical Sciences, Beijing (B.X.).

Masahisa Yamane (M)

Saitima St. Luke's International Hospital, Tokyo, Japan (M.Y.).

Luiz F Ybarra (LF)

London Health Sciences Centre, Schulich School of Medicine & Dentistry, Western University, London, Ontario, Canada (L.F.Y.).

Robert W Yeh (RW)

Beth Israel Deaconess Medical Center, Boston, MA (R.W.Y.).

Qi Zhang (Q)

Shanghai East Hospital, Tongji University, China (Q.Z.).

Stephane Rinfret (S)

McGill University Health Centre, McGill University, Montreal, QC, Canada (S.R.).

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH